I agree that this site is using cookies. You can find further informations here.
X
Firestone, Ross
38  results:
Search for persons X
?
1

Patterns of CRS with teclistamab in relapsed/refractory mul..:

Hamadeh, Issam S. ; Shekarkhand, Tala ; Rueda, Colin...
Blood Advances.  8 (2024)  12 - p. 3038-3044 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Unscheduled health care interactions in patients with multi..:

Howard, Anna J. ; Concepcion, Isabel ; Wang, Alice X....
Blood Advances.  8 (2024)  12 - p. 3246-3253 , 2024
Link: https://doi.org/10.1182/..
 
?
3

CD8 effector T cells enhance teclistamab response in BCMA-e..:

Firestone, Ross S. ; McAvoy, Devin ; Shekarkhand, Tala...
Blood Advances.  8 (2024)  7 - p. 1600-1611 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Antigen escape as a shared mechanism of resistance to BCMA-..:

Firestone, Ross S. ; Socci, Nicholas D. ; Shekarkhand, Tala...
Blood.  144 (2024)  4 - p. 402-407 , 2024
Link: https://doi.org/10.1182/..
 
?
5

Aiming for the cure in myeloma: Putting our best foot forwa..:

Bar, Noffar ; Firestone, Ross S. ; Usmani, Saad Z.
Blood Reviews.  62 (2023)  - p. 101116 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P962: COMMERCIAL TECLISTAMAB IN ANTI-BCMA THERAPY EXPOSED R..:

Firestone, Ross ; Shekarkhand, Tala ; Patel, Dhwani...
HemaSphere.  7 (2023)  S3 - p. e81198bb , 2023
Link: https://doi.org/10.1097/..
 
?
7

Reply to Willoughby:

Holzbauer, Stacy M ; Schrodt, Caroline A ; Prabhu, Rajesh M...
Clinical Infectious Diseases.  77 (2023)  6 - p. 931-932 , 2023
Link: https://doi.org/10.1093/..
 
?
8

P-013 Patterns of cytokine release syndrome with teclistama..:

Hamadeh, Issam ; Shekarkhand, Tala ; Rueda, Colin...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S40 , 2023
Link: https://doi.org/10.1016/..
 
?
9

OA-03 Bispecific T-cell engager response is driven by pre-t..:

Firestone, Ross ; McAvoy, Devin ; Shekarkhand, Tala...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S2 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P-486 Clinical significance of baseline body mass index and..:

Thirugnanasambandam, Ram Prakash ; Firestone, Ross ; Derkach, Andriy...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S307-S308 , 2023
Link: https://doi.org/10.1016/..
 
?
11

P962: COMMERCIAL TECLISTAMAB IN ANTI-BCMA THERAPY EXPOSED R..:

Ross Firestone ; Tala Shekarkhand ; Dhwani Patel...
http://journals.lww.com/10.1097/01.HS9.0000970752.81198.bb.  , 2023
Link: https://doi.org/10.1097/..
 
?
12

Current use of CAR T cells to treat multiple myeloma:

Firestone, Ross S ; Mailankody, Sham
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10727084/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

P962: COMMERCIAL TECLISTAMAB IN ANTI-BCMA THERAPY EXPOSED R..:

Firestone, Ross ; Shekarkhand, Tala ; Patel, Dhwani...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431298/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Minimal Residual Disease in Multiple Myeloma—Current Approa..:

Akhlaghi, Theresia ; Firestone, Ross ; Hultcrantz, Malin
Hemato.  3 (2022)  3 - p. 454-465 , 2022
Link: https://doi.org/10.3390/..
 
?
15

Minimal Residual Disease in Multiple Myeloma—Current Approa..:

Theresia Akhlaghi ; Ross Firestone ; Malin Hultcrantz
Plasma Cell Disorders.  , 2022
Link: https://doi.org/10.3390/..
 
1-15